BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1592425)

  • 1. Autotransplanted jejunum in patients with carcinomas of the head and neck: transport of immunosurveillance against tumor cells?
    Kornfehl J; Neuchrist C; Grasl MC; Piza H; Roka R; Ehrenberger K; Sorg C; Kraft D; Scheiner O
    Immunobiology; 1992 Apr; 184(4-5):321-35. PubMed ID: 1592425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules.
    Andersen CB; Ladefoged SD; Larsen S
    APMIS; 1994 Jan; 102(1):23-37. PubMed ID: 7513171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocutaneous flaps in patients with head and neck cancer retain their immunological capacities in an activated functional state.
    Kornfehl J; Formanek M; Knerer B; Vajs A; Moser D; Millesi W
    J Oral Pathol Med; 1997 Jan; 26(1):29-35. PubMed ID: 9021549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell carcinoma: infiltrating monocyte/macrophage subpopulations express functional mature phenotype.
    Neuchrist C; Grasl M; Scheiner O; Lassmann H; Ehrenberger K; Kraft D
    Br J Cancer; 1990 Nov; 62(5):748-53. PubMed ID: 2147109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
    Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
    Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune competent cells in non-irradiated autologous jejunal grafts used for reconstruction of the oral cavity and oropharynx.
    Millesi W; Formanek M; Moser D; Kornfehl J
    J Oral Pathol Med; 2001 Feb; 30(2):91-7. PubMed ID: 11168853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
    Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E
    Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
    Bas M; Bier H; Schirlau K; Friebe-Hoffmann U; Scheckenbach K; Balz V; Whiteside TL; Hoffmann TK
    Oral Oncol; 2006 Aug; 42(7):691-7. PubMed ID: 16527515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
    Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
    van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
    Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between autologous CD4+ and CD8+ T lymphocytes and human squamous cell carcinoma of the head and neck.
    Okada K; Yasumura S; Muller-Fleckenstein I; Fleckenstein B; Talib S; Koldovsky U; Whiteside TL
    Cell Immunol; 1997 Apr; 177(1):35-48. PubMed ID: 9140094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phenotypic changes in tumour infiltrating lymphocytes and tumour cells following intra-arterial infusion of interleukin-2 in patients with squamous cell carcinoma.
    Salter J; Maclennan KA; Moore J; Dadian G; Riches PG; Gore ME
    J Pathol; 1995 Jun; 176(2):167-73. PubMed ID: 7636627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
    Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
    Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
    Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
    Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance.
    Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2301-7. PubMed ID: 9815628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium.
    Schlesinger LS; Horwitz MA
    J Immunol; 1991 Sep; 147(6):1983-94. PubMed ID: 1679838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer.
    Andratschke M; Pauli C; Stein M; Chaubal S; Wollenberg B
    Anticancer Res; 2003; 23(2B):1467-71. PubMed ID: 12820411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy.
    Stefano S; Kerman R; Abbate J
    AJR Am J Roentgenol; 1976 Apr; 126(4):880-6. PubMed ID: 179361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.